Amal M. El-Gayar

Measurements of oxidative stress status and antioxidant activity in chronic leukaemia patients

Mohammed M.H. Al-Gayyar, Laila A. Eissa, Ahmed Rabie et al. · Journal of Pharmacy and Pharmacology · 2007 · 64 citations · Full text

Life Sciences, Hematology, Oncology +16

Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression

Salma M. Eraky, Mohamed El‐Mesery, Amro El‐Karef et al. · Biomedicine & Pharmacotherapy · 2018 · 39 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +12

Evaluation of renal protective effects of inhibiting TGF-β type I receptor in a cisplatin-induced nephrotoxicity model

Hala S Bayomi, Nehal M. Elsherbiny, Amal M. El-Gayar et al. · European Cytokine Network · 2013 · 37 citations

Medicine, Oncology, Pharmacology +17

Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme

Ahmed A. Tayel, Khaled H. Abd El Galil, Mohamed Ebrahim et al. · European Journal of Pharmacology · 2014 · 35 citations

Medicine, Oncology, Pharmacology +15

Thrombopoietin level in patients with chronic liver diseases

Laila A. Eissa, Lamees S. Gad, Ahmed Rabie et al. · Annals of Hepatology · 2008 · 30 citations · Full text

Medicine, Hematology, Pathobiology +17